Spontaneous bacterial peritonitis: A historical perspective: Kerr DNS, Pearson DT, Read AE. Infection of ascitic fluid in patients with hepatic cirrhosis [Gut 1963; 4: 394-398]

Journal of Hepatology

Volumn 41, Issue 4, 2004, Pages 522-527

  Garcia Tsao, Guadalupe ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CHLORAMPHENICOL; CISAPRIDE; NORFLOXACIN; OFLOXACIN; STREPTOMYCIN; TETRACYCLINE;

ABDOMINAL PAIN; ANAEROBIC BACTERIUM; ANTIBIOTIC THERAPY; ASCITES FLUID; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; BACTERIOSTASIS; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANDIDA ALBICANS; CLINICAL FEATURE; EARLY DIAGNOSIS; HEPATIC ENCEPHALOPATHY; HUMAN; INFECTION PREVENTION; INFECTION RISK; INTESTINE MUCOSA PERMEABILITY; INTESTINE NECROSIS; KIDNEY FAILURE; MINIMUM INHIBITORY CONCENTRATION; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY PREVENTION;

BACTERIAL INFECTIONS; HISTORY, 20TH CENTURY; HUMANS; PERITONITIS;

EID: 4644288197     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.09.001     Document Type: Note

References (47)

1. E. Krencker Bacterium coli commune als Sepsiserreger in 2 fallen von abdominaler krankungen Munchen Med Wschr 54 1907 2095
2. M. Brule, P. Hillemand, and B. Goutner Septicemie a colibacille et peritonite terminale chez une cirrhotique Bull Soc Med Hop Paris 63 1939 1167
3. M. Cachin Sur un syndrome ictero-ascitique avec colibacillemie Rev Med Chir Mal Foie 30 1955 5
4. J. Caroli, and R. Platteborse Septicemie porto-cave. Cirrhoses du foie et septicemie a colibacille Sem Hop Paris 34 1958 112 127
5. D.N.S. Kerr, D.T. Pearson, and A.E. Read Infection of ascitic fluid in patients with hepatic cirrhosis Gut 4 1963 394 398
6. H.O. Conn Spontaneous peritonitis and bacteremia in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome Ann Intern Med 60 1964 568 580
7. G. Garcia-Tsao Spontaneous bacterial peritonitis Gastro Clin North Am 21 1992 257 275
8. J. Fernandez, M. Navasa, J. Gomez, J. Colmenero, J. Vila, and V. Arroyo Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis Hepatology 35 2002 140 148
9. L.T. Evans, W.R. Kim, J.J. Poterucha, and P.S. Kamath Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites Hepatology 37 2003 897 901
10. J. Llach, A. Rimola, M. Navasa, P. Gines, J.M. Salmeron, and A. Gines Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration Hepatology 16 1992 724 727
11. M. Andreu, R. Sola, A. Sitges-Serra, C. Alia, M. Gallen, and C. Vila Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites Gastroenterology 104 1993 1133 1138
12. J. Fernandez, M. Navasa, J. Gomez, J. Colmenero, J. Vila, and V. Arroyo Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis Hepatology 35 2002 140 148
13. N. Singh, M.M. Wagener, and T. Gayowski Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit Clin Microbiol Infect 9 2003 531 537
14. A. Rimola, G. Garcia-Tsao, M. Navasa, L.J.V. Piddock, R. Planas, and B. Bernard Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document J Hepatol 32 2000 142 153
15. X. Xiol, J.M. Castellvi, J. Guardiola, E. Sese, J. Castellote, and A. Perello Spontaneous bacterial empyema in cirrhotic patients: a prospective study Hepatology 23 1996 719 723
16. J. Castellote, C. Lopez, J. Gornals, G. Tremosa, E.R. Farina, and C. Baliellas Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips Hepatology 37 2003 893 896
17. D.N. Gerding, W.H. Hall, and E.A. Schierl Antibiotic concentrations in ascitic fluid of patients with ascites and bacterial peritonitis Ann Intern Med 86 1977 708 713
18. E. Ricart, G. Soriano, M. Novella, J. Ortiz, M. Sabat, and L. Kolle Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients J Hepatol 32 2000 596 602
19. R. Terg, S. Cobas, E. Fassio, G. Landeira, B. Rios, and W. Vasen Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study J Hepatol 33 2000 564 569
20. M. Navasa, A. Follo, J.M. Llovet, G. Clemente, V. Vargas, and A. Rimola Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis Gastroenterology 111 1996 1011 1017
21. P. Sort, M. Navasa, V. Arroyo, X. Aldeguer, R. Planas, and L. Ruiz-del-Arbol Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 1999 403 409
22. L. Tito, A. Rimola, P. Gines, J. Llach, V. Arroyo, and J. Rodes Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors Hepatology 8 1988 27 31
23. P. Gines, A. Rimola, R. Planas, V. Vargas, F. Marco, and M. Almela Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial Hepatology 12 1990 716 724
24. T.M. Bauer, A. Follo, M. Navasa, J. Vila, R. Planas, and G. Clemente Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence Dig Dis Sci 47 2002 1356 1361
25. B. Campillo, C. Dupeyron, J.P. Richardet, N. Mangeney, and G. Leluan Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin Clin Infect Dis 26 1998 1066 1070
26. M. Deschenes, and J.P. Villeneuve Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis Am J Gastroenterol 94 1999 2193 2197
27. B. Bernard, J.D. Grange, E.N. Khac, X. Amiot, P. Opolon, and T. Poynard Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis Hepatology 29 1999 1655 1661
28. M.C. Hou, H.C. Lin, T.T. Liu, B.I. Kuo, F.Y. Lee, and F.Y. Chang Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial Hepatology 39 2004 746 753
29. J.D. Grange, D. Roulot, G. Pelletier, E.A. Pariente, J. Denis, and O. Ink Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites - A double-blind randomized trial J Hepatol 29 1998 430 436
30. C. Guarner, R. Sola, G. Soriano, M. Andreu, M.T. Novella, and C. Vila Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels Gastroenterology 117 1999 414 419
31. G. Garcia-Tsao, F.Y. Lee, G.E. Barden, R. Cartun, and A.B. West Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites Gastroenterology 108 1995 1835 1841
32. I. Cirera, T.M. Bauer, M. Navasa, J. Vila, L. Grande, and P. Taura Bacterial translocation of enteric organisms in patients with cirrhosis J Hepatol 34 2001 32 37
33. J.M. Llovet, R. Bartoli, F. March, R. Planas, B. Vinado, and E. Cabre Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence J Hepatol 28 1998 307 313
34. A. Rimola, F. Bory, J. Teres, R.M. Perez-Ayuso, V. Arroyo, and J. Rodes Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage Hepatology 5 1985 463 467
35. G. Soriano, C. Guarner, A. Tomas, C. Villanueva, X. Torras, and D. Gonzalez Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage Gastroenterology 103 1992 1267 1272
36. P. Gines, A. Rimola, R. Planas, V. Vargas, F. Marco, and M. Almela Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial Hepatology 12 1990 716 724
37. A. Rimola, R. Soto, F. Bory, V. Arroyo, C. Piera, and J. Rodes Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis Hepatology 4 1984 53 58
38. C. Homann, K. Varming, K. Hogasen, T.E. Mollnes, N. Graudal, and A.C. Thomsen Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality Gut 40 1997 544 549
39. B.A. Runyon, R.L. Morrissey, J.C. Hoefs, and F.A. Wyle Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis Hepatology 5 1985 634 637
40. G. Garcia-Tsao, and R. Wiest Gut microflora in the pathogenesis of the complications of cirrhosis Best Pract Res Clin Gastroenterol 18 2004 353 372
41. M. Perez-Paramo, J. Munoz, A. Albillos, I. Freile, F. Portero, and M. Santos Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites Hepatology 31 2000 43 48
42. A. Pardo, R. Bartoli, V. Lorenzo-Zuniga, R. Planas, B. Vinado, and J. Riba Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis Hepatology 31 2000 858 863
43. S.C. Zhang, W. Wang, W.Y. Ren, B.M. He, K. Zhou, and W.N. Zhu Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis World J Gastroenterol 9 2003 534 538
44. A.M. Madrid, C. Hurtado, M. Venegas, F. Cumsille, and C. Defilippi Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function Am J Gastroenterol 96 2001 1251 1255
45. R. Wiest, F. Chen, G. Cadelina, R.J. Groszmann, and G. Garcia-Tsao Effect of Lactobacillus-fermented diets on bacterial translocation and intestinal flora in experimental prehepatic portal hypertension Dig Dis Sci 48 2003 1136 1141
46. T.M. Bauer, J. Fernandez, M. Navasa, J. Vila, and J. Rodes Failure of Lactobacillus spp. to prevent bacterial translocation in a rat model of experimental cirrhosis J Hepatol 36 2002 501 506
47. V. Lorenzo-Zuniga, R. Bartoli, R. Planas, A.F. Hofmann, B. Vinado, and L.R. Hagey Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats Hepatology 37 2003 551 557